SCHEMBL844932

SCHEMBL844932

CC(C)(C)C(=O)[C@H]1CCN(C(=O)O)C1

nearest known ligand 0.43

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 4/20 0.34
RECQL P46063 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HRH3 Q9Y5N1 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1780483 0.89 ALDH1A1 (0.40) LMNAHPGDSMN1; SMN2ALDH1A1MEN1
SCHEMBL23582550 0.89 ALDH1A1 (0.40) LMNAHPGDSMN1; SMN2ALDH1A1MEN1
SCHEMBL3503877 0.88 LMNA (0.46) LMNAHPGDSMN1; SMN2ALDH1A1RECQL
SCHEMBL344570 0.81 LMNA (0.41) LMNAHPGDSMN1; SMN2ALDH1A1RECQL
SCHEMBL22468381 0.81 LMNA (0.36) LMNAHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL16886295 0.80 EPHX2 (0.44) LMNAHPGDALDH1A1MEN1KMT2A
SCHEMBL7440334 0.78 LMNA (0.34) LMNAHPGDALDH1A1GAATSHR
SCHEMBL12539837 0.78 LMNA (0.39) LMNAHPGDSMN1; SMN2ALDH1A1POLB
SCHEMBL25317162 0.78 LMNA (0.39) LMNAHPGDSMN1; SMN2ALDH1A1POLB
SCHEMBL25313461 0.78 LMNA (0.39) LMNAHPGDSMN1; SMN2ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022234867-A1 SULFONAMIDE HAVING MMP 7-INHIBITING ACTION 大正製薬株式会社 2022-11-10 WO disclosed
EP-2432555-A1 N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS Incyte Corporation (US) 2012-03-28 EP disclosed